Drug major

Lupin to market Novartis' inhaler under Loftair brand name

Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India

Apr 11, 2016, 17:24 PM IST

Lupin launches generic insomnia drug in US

Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.

Apr 05, 2016, 13:56 PM IST

Lupin receives nine observations from USFDA for Goa plant

Drug major Lupin on Tuesday says that it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (USFDA)

Mar 15, 2016, 18:09 PM IST

Lupin acquires Russian drug firm Biocom

The company has acquired 100 per cent equity stake in ZAO Biocom in Russia subject to certain closing conditions, Lupin Ltd said in a statement without disclosing the financial details.

Jul 02, 2015, 19:49 PM IST

Lupin gets Board's nod to raise funds up to Rs 7,500 crore

Drug major Lupin on Tuesday said its Board of Directors have given in-principle approval for raising funds of up to Rs 7,500 crore.

Jun 23, 2015, 10:56 AM IST

Lupin to acquire additional 40% stake in SA's Pharma Dynamics

Lupin had earlier acquired 60 per cent stake in the South African (SA) firm in September, 2008.

Mar 16, 2015, 15:24 PM IST

Lupin eyes acquisitions in US, Europe

Drug major Lupin is eyeing acquisitions in various global markets, including the US, Latin America and Europe, as it looks to bolster its presence overseas.

Dec 28, 2014, 13:56 PM IST

Lupin scouts for acquisitions in US

Looking to bolster its overseas presence, drug major Lupin is scouting for acquisition opportunities in the US market, especially in inhalers and injectables segments.

Oct 21, 2014, 13:43 PM IST